CEO SUMMARY: In a surprise move that further consolidates national anatomic pathology services, NeoGenomics will acquire Clarient Inc., from General Electric Healthcare. General Electric is getting cash, and preferred and common stock. The two companies announced plans to pursue integrated diagnostic services that would combine lab testing and diagnostic imaging data. The deal is subject
NeoGenomics to Acquire Clarient for $275 Million
By Joseph Burns, from the Volume XXII NO. 15 - October 26, 2015 issue